Dopamine D1 receptors facilitate transmitter release

Donald L. Cameron, John Williams

Research output: Contribution to journalArticle

225 Citations (Scopus)

Abstract

A PHYSIOLOGICAL role for the dopamine D1 receptor has been difficult to define, particularly because of its complex pre- and postsynaptic localization in brain areas such as the striatum1. In the midbrain, however, D1 receptors are selectively localized to the terminals of GABA (γ-aminobutyric acid)-containing afferents2-4. We have studied the actions of these D1 receptors on evoked GABA synaptic potentials recorded intracellularly from dopamine neurons in the ventral tegmental area (VTA). We report here that dopamine augmented GABAB inhibitory postsynaptic potentials (i.p.s.ps) in the presence of D2 receptor antagonists. This effect was mimicked by the D1 agonists SKF3S393 and SKF82958 and blocked by the D1 antagonists SCH23390 and cis-flupenthixol. No modulation of the GABAA synaptic potential was observed. The postsynaptic actions of the GABAB agonist, baclofen, were unaffected by SKF38393, SCH23390 or cis-flupenthixol, confirming a presynaptic locus of D1 action. Additionally, D1 antagonists reduced the amplitude of the GABAB i.p.s.p. in the absence of D1 agonists. We conclude that dopamine acts tonically at presynaptic Dl receptors on the terminals of afferent GABA neurons to facilitate selectively GABAB-mediated neurotransmission in the midbrain.

Original languageEnglish (US)
Pages (from-to)344-347
Number of pages4
JournalNature
Volume366
Issue number6453
StatePublished - Nov 25 1993

Fingerprint

Flupenthixol
Dopamine D1 Receptors
Synaptic Potentials
Mesencephalon
gamma-Aminobutyric Acid
Dopamine
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Aminobutyrates
Presynaptic Receptors
Afferent Neurons
GABAergic Neurons
Inhibitory Postsynaptic Potentials
Ventral Tegmental Area
Baclofen
Dopaminergic Neurons
Synaptic Transmission
Brain
SCH 23390

ASJC Scopus subject areas

  • General

Cite this

Dopamine D1 receptors facilitate transmitter release. / Cameron, Donald L.; Williams, John.

In: Nature, Vol. 366, No. 6453, 25.11.1993, p. 344-347.

Research output: Contribution to journalArticle

Cameron, DL & Williams, J 1993, 'Dopamine D1 receptors facilitate transmitter release', Nature, vol. 366, no. 6453, pp. 344-347.
Cameron, Donald L. ; Williams, John. / Dopamine D1 receptors facilitate transmitter release. In: Nature. 1993 ; Vol. 366, No. 6453. pp. 344-347.
@article{3065e15e796642b2973f11368758537c,
title = "Dopamine D1 receptors facilitate transmitter release",
abstract = "A PHYSIOLOGICAL role for the dopamine D1 receptor has been difficult to define, particularly because of its complex pre- and postsynaptic localization in brain areas such as the striatum1. In the midbrain, however, D1 receptors are selectively localized to the terminals of GABA (γ-aminobutyric acid)-containing afferents2-4. We have studied the actions of these D1 receptors on evoked GABA synaptic potentials recorded intracellularly from dopamine neurons in the ventral tegmental area (VTA). We report here that dopamine augmented GABAB inhibitory postsynaptic potentials (i.p.s.ps) in the presence of D2 receptor antagonists. This effect was mimicked by the D1 agonists SKF3S393 and SKF82958 and blocked by the D1 antagonists SCH23390 and cis-flupenthixol. No modulation of the GABAA synaptic potential was observed. The postsynaptic actions of the GABAB agonist, baclofen, were unaffected by SKF38393, SCH23390 or cis-flupenthixol, confirming a presynaptic locus of D1 action. Additionally, D1 antagonists reduced the amplitude of the GABAB i.p.s.p. in the absence of D1 agonists. We conclude that dopamine acts tonically at presynaptic Dl receptors on the terminals of afferent GABA neurons to facilitate selectively GABAB-mediated neurotransmission in the midbrain.",
author = "Cameron, {Donald L.} and John Williams",
year = "1993",
month = "11",
day = "25",
language = "English (US)",
volume = "366",
pages = "344--347",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "6453",

}

TY - JOUR

T1 - Dopamine D1 receptors facilitate transmitter release

AU - Cameron, Donald L.

AU - Williams, John

PY - 1993/11/25

Y1 - 1993/11/25

N2 - A PHYSIOLOGICAL role for the dopamine D1 receptor has been difficult to define, particularly because of its complex pre- and postsynaptic localization in brain areas such as the striatum1. In the midbrain, however, D1 receptors are selectively localized to the terminals of GABA (γ-aminobutyric acid)-containing afferents2-4. We have studied the actions of these D1 receptors on evoked GABA synaptic potentials recorded intracellularly from dopamine neurons in the ventral tegmental area (VTA). We report here that dopamine augmented GABAB inhibitory postsynaptic potentials (i.p.s.ps) in the presence of D2 receptor antagonists. This effect was mimicked by the D1 agonists SKF3S393 and SKF82958 and blocked by the D1 antagonists SCH23390 and cis-flupenthixol. No modulation of the GABAA synaptic potential was observed. The postsynaptic actions of the GABAB agonist, baclofen, were unaffected by SKF38393, SCH23390 or cis-flupenthixol, confirming a presynaptic locus of D1 action. Additionally, D1 antagonists reduced the amplitude of the GABAB i.p.s.p. in the absence of D1 agonists. We conclude that dopamine acts tonically at presynaptic Dl receptors on the terminals of afferent GABA neurons to facilitate selectively GABAB-mediated neurotransmission in the midbrain.

AB - A PHYSIOLOGICAL role for the dopamine D1 receptor has been difficult to define, particularly because of its complex pre- and postsynaptic localization in brain areas such as the striatum1. In the midbrain, however, D1 receptors are selectively localized to the terminals of GABA (γ-aminobutyric acid)-containing afferents2-4. We have studied the actions of these D1 receptors on evoked GABA synaptic potentials recorded intracellularly from dopamine neurons in the ventral tegmental area (VTA). We report here that dopamine augmented GABAB inhibitory postsynaptic potentials (i.p.s.ps) in the presence of D2 receptor antagonists. This effect was mimicked by the D1 agonists SKF3S393 and SKF82958 and blocked by the D1 antagonists SCH23390 and cis-flupenthixol. No modulation of the GABAA synaptic potential was observed. The postsynaptic actions of the GABAB agonist, baclofen, were unaffected by SKF38393, SCH23390 or cis-flupenthixol, confirming a presynaptic locus of D1 action. Additionally, D1 antagonists reduced the amplitude of the GABAB i.p.s.p. in the absence of D1 agonists. We conclude that dopamine acts tonically at presynaptic Dl receptors on the terminals of afferent GABA neurons to facilitate selectively GABAB-mediated neurotransmission in the midbrain.

UR - http://www.scopus.com/inward/record.url?scp=0027378581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027378581&partnerID=8YFLogxK

M3 - Article

VL - 366

SP - 344

EP - 347

JO - Nature

JF - Nature

SN - 0028-0836

IS - 6453

ER -